SonoThera Showcases RIPPLE Gene Delivery Breakthrough for DMD
SOUTH SAN FRANCISCO, California – March 5, 2026 SonoThera announced new preclinical research demonstrating the potential of its proprietary...
Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody NSCLC Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
SOUTH SAN FRANCISCO, California – March 5, 2026 SonoThera announced new preclinical research demonstrating the potential of its proprietary...
SAN DIEGO, Calif., February 26, 2026 Avidity Biosciences, Inc. (Nasdaq: RNA) announced that it will present one oral and...
NASHVILLE, Tenn., Feb. 4, 2026 —Cumberland Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration has granted Fast...
MILAN, Italy & HYOGO, Japan | December 24, 2025 — Italfarmaco and JCR Pharmaceuticals have announced a landmark commercialisation...
